Navigation Links
Tests Confirm HandClens(R) Hand Sanitizer Kills H1N1 Flu Virus

ALISO VIEJO, Calif., Aug. 31 /PRNewswire/ -- Woodward Labs, a leading antimicrobial skin care company, announced today that an independent testing laboratory has confirmed the efficacy of HandClens, an alcohol-free hand sanitizer, against H1N1 flu virus. The test results show HandClens is 99.99% effective against H1N1 virus in 15 seconds. The company will submit these results to the FDA as an addendum to its citizen's petition from 2003 that details how the company's patented formula effectively kills 99.99 percent of disease-causing germs.

This is timely as The Centers for Disease Control (CDC) recently recognized that "hand sanitizers that do not contain alcohol may be useful for killing flu germs on hands." With over a decade of research behind Woodward Lab's alcohol-free formula, HandClens(R) is an important tool in the battle to stay healthy during flu season.

The testing was conducted by a Good Laboratory Practices (GLP) compliant, independent third party laboratory following American Society for Testing and Materials (ASTM) International protocol.

"We want the public to recognize HandClens(R) as an effective way to prevent the spread of H1N1 Flu and other germs," says Marwan Zreik, president of Woodward Labs. "With the H1N1 pandemic expected to continue this fall and a minimal amount of inoculations available, the public needs another level of defense against the spread of micro-organisms and our testing proves that HandClens(R) will help kill the germs that cause illness."

According to Zreik, "Experts say to wash hands often, but for those times when access to soap and water are limited, the public needs another option. The alcohol-free component of HandClens(R) is especially important in facilities where the flammability and toxicity of alcohol-based sanitizers is a concern."

Alcohol-free hand sanitizers are safer for children because they are non-toxic, non-flammable and eliminate the risk of alcohol ingestion, as has happened in the recent-past with alcohol-based sanitizers. In addition, alcohol-free products are gentler on the skin and don't cause drying or cracking.

According to scientific reports submitted to the FDA, also published in both the Journal of School Nursing and Family Medicine Journal, schools that instituted HandClens as part of an overall classroom hand-hygiene program showed as much as a 42 percent reduction in illness-absenteeism in students ages four-to-12 years old.

Woodward Labs aims to help prevent the spread of Swine Flu by continuing to offer special programs to schools, institutions and consumers. This includes online price discounts, free wall dispensers and a free "Simple as ABC, 'Always Be Clean,'" hand hygiene instruction manual, a comprehensive education program designed by Woodward to help parents and teachers promote the importance of proper hand hygiene to kids and adolescents grades K-8 in a fun and engaging way.

HandClens is available in a variety of sizes including 0.5 oz, 1.7 oz, 8.0 oz and institutional 1.0 liter and 1.8 liter sizes. HandClens has a wonderful green apple scent and is available directly through Woodward Labs and its distributors. For more information, please visit

About Woodward Laboratories

Founded in 1992, Woodward Laboratories manufactures leading antimicrobial germ-killing skincare products that provide a healthier way of living. Woodward Laboratories uses its patented proprietary delivery systems in its foot care, nail care and hand care products and is best known for its Mycocide, Dr. G's, HandClens and its Diabetic Basics brands.

SOURCE Woodward Laboratories
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Experts propose cholesterol tests at 15 months of age
2. Fecal Blood Tests Effective at Spotting Colon Cancer
3. Drug Industry Seeks Tests to Spot Side Effect Risks
4. Noninvasive tests for cirrhosis may help to avoid liver biopsy
5. K-State Veterinary Lab Routinely Tests For Bluetongue Virus; Lab Director Says Strains Found in Kansas, U.S. Usually Less-Virulent
6. Gene Tests Match Up Lung Tumors, Best Treatment
7. Mayo Clinic tests novel vaccine for aggressive brain tumors
8. Cepheid and Broadlane Sign Group Purchasing Contract for GeneXpert(R) Systems and Xpert(TM) Molecular Diagnostic Tests, Including Xpert MRSA
9. Bone Density Tests Do Predict Womens Fracture Risk
10. Mini stress tests could help condition heart to survive major attack
11. Lab on a chip developed at University of Alberta for cheap, portable medical tests
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... Baptist Medical Center ... and is the only hospital in the region providing what is known as ... transcatheter pacing patients were revealed recently at a medical conference and published in ...
(Date:12/1/2015)... MD (PRWEB) , ... December 01, 2015 , ... ... salmon identification tests to continue the expansion of the company’s growing product line ... – for Chinook (Oncorhynchus tshawytscha) and Sockeye (Oncorhynchus nerka) – allow InstantLabs to ...
(Date:12/1/2015)... New York, NY (PRWEB) , ... December 01, ... ... cause of non-traumatic limb amputations in the United States. Podiatrists are well aware ... (failure to adopt therapeutic behaviors) are often catastrophic contributors to diseases of the ...
(Date:12/1/2015)... CA (PRWEB) , ... December 01, 2015 , ... ... Health Center of Excellence (BHCOE) today announced that the organization has awarded Education ... San Francisco, with a Distinguished Award. The award celebrates exceptional special needs providers ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... for Effective Post-Affiliation Integration ,” addresses a main “pain point” for merging or ... anticipated results, once a deal is signed. This quick-read guidance suggests that ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... During the recent 2015 Transcatheter Cardiovascular ... CA , Medinol Ltd. continued to introduce ... a satellite symposium, "The BioNIR eDES: The Role ... a renowned physician panel discussed the key attributes ... Stent System and the Medinol eDES Coronary Stent ...
(Date:12/1/2015)... YORK , Dec. 1, 2015 Relmada Therapeutics, ... the treatment of chronic pain, announced today that the company ... will be held December 1-3 at the Luxe Sunset Boulevard ... Sergio Traversa , CEO of Relmada Therapeutics, will present on ... Eastern Time). . Please register at least ...
(Date:12/1/2015)... Dec. 1, 2015  InCarda Therapeutics, Inc. (InCarda), a ... of therapies for cardiovascular conditions via the inhalation route, ... in Australia . InCarda is planning ... Australia in the first half of ... medical centers in Adelaide and ...
Breaking Medicine Technology: